Insider Shareholders with Direct Ownership of Pear Therapeutics, Inc. (PEAR)
This section provides a comprehensive overview of the insiders with direct ownership of Pear Therapeutics, Inc. (PEAR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Pear Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Corey Mc Cann
President and CEO |
8,245,656 | 34,731 | 8,210,834 $82,108 | 3 |
Jan 20, 2023
Reduced 0.42%
|
Lj10 Llc
> 10% Shareholder |
6,540,000 | 430,000 | 6,110,000 $61,100 | 2 |
Dec 09, 2022
Reduced 6.57%
|
Yuri Maricich
Chief Medical Officer |
104,420 | 12,162 | 94,333 $943 | 3 |
Jan 20, 2023
Reduced 11.42%
|
Alison Bauerlein
Director |
71,428 | 0 | 71,428 $714 | 1 |
Feb 15, 2023
Added 50.0%
|
Nancy M Schlichting
Director |
66,666 | 0 | 66,666 $666 | 1 |
Feb 15, 2023
Added 50.0%
|
Kirthiga Reddy
Director |
61,904 | 0 | 61,904 $619 | 1 |
Feb 15, 2023
Added 50.0%
|
Paul Mango
Director |
52,380 | 0 | 52,380 $523 | 1 |
Feb 15, 2023
Added 50.0%
|
Timothy A Wicks
Director |
52,380 | 0 | 52,380 $523 | 1 |
Feb 15, 2023
Added 50.0%
|
Shivakumar Rajaraman
Director |
52,380 | 0 | 52,380 $523 | 1 |
Feb 15, 2023
Added 50.0%
|
Erin K. Brenner
Chief Product Dev. Officer |
52,000 | 8,690 | 43,310 $433 | 4 |
Jan 20, 2023
Reduced 16.71%
|
Christopherd T Guiffre
CFO, COO, Treas., & Asst. Sec. |
49,500 | 19,540 | 29,960 $299 | 2 |
Jan 20, 2023
Reduced 39.47%
|
Julia Strandberg
Chief Commercial Officer |
33,000 | 12,688 | 28,612 $286 | 2 |
Jan 20, 2023
Reduced 30.72%
|
Ellen Snow
VP, Chief Accounting Officer |
20,320 | 8,027 | 23,318 $233 | 2 |
Jan 20, 2023
Reduced 25.61%
|
Ronan O'Brien
CCO, GC, & Secretary |
30,800 | 12,162 | 18,638 $186 | 2 |
Jan 20, 2023
Reduced 39.49%
|
Katherine Jeffery
Chief People Officer |
15,400 | 7,096 | 8,304 $83 | 2 |
Jan 20, 2023
Reduced 46.08%
|